Chronic Oral Exposure to Inorganic Arsenate Interferes with Methylation Status of p16INK4a and RASSF1A and Induces Lung Cancer in A/J Mice
Open Access
- 16 March 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 91 (2) , 372-381
- https://doi.org/10.1093/toxsci/kfj159
Abstract
Although inorganic arsenate (iAsV) or arsenite (iAsIII) is clearly a human carcinogen, it has been difficult to produce tumors in rodents. In the present study, we orally administered iAsV to A/J mice to examine arsenic carcinogenicity in rodent. A/J mice (male, n = 120) assigned to four groups were given drinking water containing 0, 1, 10, and 100 ppm iAsV for 18 months. At the end of experiment, the complete lungs were removed and used for examining histopathology and extracting RNA and DNA. Epigenetic effects of iAsV on DNA methylation patterns of p16INK4a and RASSF1A genes were determined by methylation-specific polymerase chain reaction. Changes of p16INK4a and RASSF1A at mRNA and protein levels were examined by reverse transcriptase–polymerase chain reaction and immunohistochemistry. Arsenic was accumulated dose dependently in the lung tissues of iAsV-exposed mice. Increase in lung tumor number and lung tumor size was observed in iAsV-exposed mice compared to the control. Histopathological examination showed that the rate of poorly differentiated lung adenocarcinoma was much higher in iAsV-exposed mice than in the control. Methylation rates appeared to be higher in a dose-related tendency in lung tumors from iAsV-exposed mice compared to the control. Lower or loss of p16INK4a and RASSF1A expression was found in lung tumors from iAsV-exposed mice, compared to that in nontumor lung tissues from both control and iAsV-exposed mice, and this reduced or lost expression was in accordance with hypermethylation of the genes. In conclusion, iAsV exposure increased lung tumor incidence and multiplicity in A/J mice. Epigenetic changes of tumor suppressor genes such as p16INK4a and RASSF1A are involved in the iAsV-induced lung carcinogenesis.Keywords
This publication has 33 references indexed in Scilit:
- DNA Hypermethylation of Promoter of Gene p53 and p16 in Arsenic-Exposed People with and without MalignancyToxicological Sciences, 2005
- Silencing of genes by promoter hypermethylation: key event in rodent and human lung cancerCarcinogenesis: Integrative Cancer Research, 2005
- Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/ArfOncogene, 2004
- A new metabolic pathway of arsenite: arsenic?glutathione complexes are substrates for human arsenic methyltransferase Cyt19Archives of Toxicology, 2004
- Value of p16 INK4a and RASSF1A Promoter Hypermethylation in Prognosis of Patients with Resectable Non–Small Cell Lung CancerClinical Cancer Research, 2004
- Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesisCarcinogenesis: Integrative Cancer Research, 2004
- Subchronic Exposure to Arsenic Through Drinking Water Alters Expression of Cancer-Related Genes in Rat LiverToxicologic Pathology, 2004
- Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancersCarcinogenesis: Integrative Cancer Research, 2003
- The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 AccumulationMolecular and Cellular Biology, 2002
- Mechanisms of p16INK4A inactivation in non small-cell lung cancersOncogene, 1998